Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Plans National Medicare Rx Presence: At Risk But Invisible

This article was originally published in The Pink Sheet Daily

Executive Summary

The PBM plans to create "chassis" for health care plans and employers to customize in offering Part D plans in 2006 and beyond. Time will work in Medco's favor, the company says, because many customers are unlikely to be ready with all the elements of a bid by CMS' deadline.

You may also be interested in...



Medco, GSK Reach Formulary Agreement For Medicare Part D

Medco describes the agreement as an "innovative collaboration" in a press release. Under the deal, Medco and GSK will share responsibility for providing access to and ensuring appropriate use of the products, the PBM said.

Medco, GSK Reach Formulary Agreement For Medicare Part D

Medco describes the agreement as an "innovative collaboration" in a press release. Under the deal, Medco and GSK will share responsibility for providing access to and ensuring appropriate use of the products, the PBM said.

Ovations Chooses Walgreens PBM To Administer Medicare Part D Plan

The health plan says its choice of Walgreens reflects the consumer-based focus of the Part D market. Ovations parent company UnitedHealth Group is Medco's largest health plan client and continues to have a strong relationship with Medco with respect to the group-based business, Ovations says.

Related Content

Topics

UsernamePublicRestriction

Register

PS061554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel